文献速递临床免疫

儿童朗格汉斯细胞组织细胞增生症患者中的抗IgLON5病一例

Anti-IgLON5 disease in a pediatric patient with Langerhans cell histiocytosis.
PubMed 文献 · Clin Chim Acta · 2021-07-14

本文报告一例患有朗格汉斯细胞组织细胞增生症(LCH)的儿童在化疗期间逐渐出现肌张力增高和眼震,颅脑影像显示脑膜强化,通过间接免疫荧光法中的细胞基础实验(CBA)检测到血清IgLON5 IgG抗体(1:30),确诊为抗IgLON5病。抗IgLON5病在儿童中极为罕见,几乎未见报道,临床医生应提高对该病的认识并重视自身免疫抗体检测。

要点

  • 儿童抗IgLON5病极为罕见,几乎未见报道。
  • LCH患儿化疗中出现肌张力增高、眼震及脑膜强化需警惕抗IgLON5病。
  • 血清IgLON5 IgG抗体(1:30)经CBA法检测可确诊。

核心结论

  • 抗IgLON5病在儿童中罕见,几乎无儿童病例报道,临床医生应提高认识并重视自身免疫抗体检测。

研究设计与样本

  • 病例报告:一例患有朗格汉斯细胞组织细胞增生症(LCH)的儿童,在化疗期间逐渐出现肌张力增高和眼震,颅脑影像显示脑膜强化。

主要发现

  • 患儿在化疗期间逐渐出现肌张力增高和眼震,颅脑影像显示脑膜强化。
  • 因缺乏LCH中枢神经系统侵犯的证据,采用间接免疫荧光法中的细胞基础实验(CBA)检测自身免疫性脑炎相关抗体。
  • 血清中检出IgLON5 IgG抗体(1:30),结合睡眠障碍和运动障碍的临床表现,确诊为抗IgLON5病。

关键数值与推荐

  • 血清IgLON5 IgG抗体滴度为1:30(细胞基础实验,间接免疫荧光法)。

临床怎么用

  • 对患有其他合并症的儿童,若出现睡眠障碍、运动障碍等难以识别的症状,应警惕抗IgLON5病并检测自身免疫抗体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Anti-IgLON5 disease is a rare autoimmune disease of the central nervous system. Different from the previous autoimmune encephalitis, the disease is a chronic progressive disease characterized by abnormal sleep, sleep apnea and motor disorders, which is prone to misdiagnosis and missed diagnosis. METHODS: We report a unique case of anti-IgLON5 disease in a pediatric patient with Langerhans cell histiocytosis (LCH). He gradually developed increased muscle tone and nystagmus during chemotherapy and showed signs of meningeal enhancement on cranial imaging. Due to insufficient evidence of LCH invasion of the central nervous system, the presence of autoimmune encephalitis-related antibodies was investigated by using cell-based assay (CBA) experiment in indirect immuno-fluorescence assay (IFA). RESULTS: Clinical manifestations of sleep disorders and motor disorders, plus the presence of IgLON5 IgG antibodies (1:30) in the serum leading to a confirmed diagnosis of anti-IgLON5 disease. CONCLUSION: Anti-IgLON5 disease is rare and almost no cases of children have been reported. In view of the difficult to recognize symptoms in pediatric patients, especially those with other comorbidities. Clinicians should raise their awareness of this disease and pay attention to the detection of autoimmune antibodies.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Ye F, Fan C, Peng M, et al. Anti-IgLON5 disease in a pediatric patient with Langerhans cell histiocytosis. Clin Chim Acta. 2021. PMID: 34270954. doi:10.1016/j.cca.2021.07.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。